Kurano, T.; Kanazawa, T.; Iioka, S.; Kondo, H.; Kosuge, Y.; Suzuki, T.
Intranasal Administration of N-acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics 2022, 14, 2590.
https://doi.org/10.3390/pharmaceutics14122590
AMA Style
Kurano T, Kanazawa T, Iioka S, Kondo H, Kosuge Y, Suzuki T.
Intranasal Administration of N-acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics. 2022; 14(12):2590.
https://doi.org/10.3390/pharmaceutics14122590
Chicago/Turabian Style
Kurano, Takumi, Takanori Kanazawa, Shingo Iioka, Hiromu Kondo, Yasuhiro Kosuge, and Toyofumi Suzuki.
2022. "Intranasal Administration of N-acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis" Pharmaceutics 14, no. 12: 2590.
https://doi.org/10.3390/pharmaceutics14122590
APA Style
Kurano, T., Kanazawa, T., Iioka, S., Kondo, H., Kosuge, Y., & Suzuki, T.
(2022). Intranasal Administration of N-acetyl-L-cysteine Combined with Cell-Penetrating Peptide-Modified Polymer Nanomicelles as a Potential Therapeutic Approach for Amyotrophic Lateral Sclerosis. Pharmaceutics, 14(12), 2590.
https://doi.org/10.3390/pharmaceutics14122590
